Skip to main content
Premium Trial:

Request an Annual Quote

JGI Purchases $500K Sequencing System from 454

NEW YORK, Aug. 1 (GenomeWeb News) - The US Department of Energy's Joint Genome Institute has purchased a $500,000 genome sequencing system from 454 Life Sciences, an institute official said today.

 

454, a subsidiary of CuraGen, has developed a system that accelerates sequencing processes through the use of microfluidics and other methods of miniaturizing current technology. Previously, the Brandford, Conn.-based company offered use of the system as a service.

 

In March, GenomeWeb News reported that 454 had installed the first system at HarvardUniversity's and MIT's Broad Institute.

 

454 recently described its sequencing technology in a paper in the July 31 online issue of Nature. In the paper, researchers from the company used the system to re-sequence 580,069 bases of the genome of the bacterium Mycoplasma genitalium in one four-hour run with up to 99.99 percent accuracy -- a 100-fold increase in throughput over current sequencing technology, according to the company.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.